Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-009129
Filing Date
2013-02-14
Accepted
2013-02-14 16:14:02
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q v332850_10q.htm 10-Q 507855
2 EXHIBIT 31.1 v332850_ex31-1.htm EX-31.1 18475
3 EXHIBIT 31.2 v332850_ex31-2.htm EX-31.2 10654
4 EXHIBIT 32.1 v332850_ex32-1.htm EX-32.1 5039
5 EXHIBIT 32.2 v332850_ex32-2.htm EX-32.2 5175
  Complete submission text file 0001144204-13-009129.txt   3894384

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20121231.xml EX-101.INS 519026
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20121231.xsd EX-101.SCH 42428
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20121231_cal.xml EX-101.CAL 38916
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20121231_def.xml EX-101.DEF 171342
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20121231_lab.xml EX-101.LAB 294525
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20121231_pre.xml EX-101.PRE 223227
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 13613965
SIC: 2834 Pharmaceutical Preparations